Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05599568

Repeated Bout Effect i Neuromuscular Diseases

The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs).

In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Neuromuscular Research Unit, 3342

Copenhagen, DK-2100, Denmark

Location status: Recruiting

About this study

The repeated bout effect (RBE) refers to the adaptation whereby a single bout of eccentric exercise protects against muscle damage from subsequent eccentric bouts. This effect has been shown in many muscle groups using both serum biomarkers, muscle soreness and imaging techniques. Though the effect is well described in healthy, it has never been studied in patients with neuromuscular diseases (NMDs).

NMDs are a common term for diseases that affect the muscles by disease processes in the motor neuron, peripheral nerve, neuromuscular junction or the muscles. The diseases can cause symptoms such as muscle weakness, muscle fatigue and sometimes muscle pain and varying degrees of physical disability. As the mechanisms for disease varies among NMDs, it is likely that some patients will experience RBE in a similar fashion to healthy, while others may not.

Recent years have shown significant breakthrough in the treatment development for various NMDs, and many of these treatments are currently or will soon be evaluated in clinical trials. As many trials will use exercise to evaluate treatment effect, it is vital to understand whether a single bout of exercise in itself provides a protective effect on the muscles of patients with NMDs.

In healthy, the RBE is only described using eccentric exercise, but unlike healthy persons, patients with NMDs can experience significant muscle damage with concentric exercise. This raises the question, if patients with NMDs could also show RBE when performing concentric exercise.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 18 years
  • The ability to complete the exercise challenge
  • No concurrent medical condition that could interfere with interpretation of the results
  • Molecular diagnosis of the specific condition in specified patient groups or healthy control
  • No active muscle injury on the test day (caused by recent exercise, seizures, trauma, etc.)

Exclusion criteria

  • Cardiac or pulmonary disease contraindicating peak exercise testing or strenuous exercise defined as NYHA-class III-IV
  • Veins that are too difficult to puncture for blood sampling, evaluated by the investigator
  • Severe muscle weakness, that prevents the subject completing the exercise test, evaluated by the investigator

Treatment and study plan

Exercise

Other

Either concentric or excentric exercise

Primary outcomes

  1. Delta CK

    Time frame: 1 month

    Change in peak kreatine kinase following first and second exercise bout.

Study contacts

Contact information is provided by the study sponsor or research team.

Mads Stemmerik, MD

CONTACT

[email protected]

+4535456126

Sponsors and collaborators

Lead sponsor

Mads Peter Godtfeldt Stemmerik

Other

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Oct 31, 2022
Registry last updated
Apr 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.